{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:53:01Z","timestamp":1794001981822,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40894-9","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T03:44:45Z","timestamp":1772682285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["WNT inhibition activates interferon stimulated gene expression by alleviating epigenetic repression of endogenous retroviruses"],"prefix":"10.1038","volume":"16","author":[{"given":"Courtney M.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Harper","family":"Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varenka Rodriguez","family":"DiBlasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis Jinrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Nuwayhid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Cevasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namita T.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"40894_CR1","doi-asserted-by":"publisher","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","volume":"2","author":"A Haslam","year":"2019","unstructured":"Haslam, A. & Prasad, V. Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs. JAMA Netw. Open. 2, e192535. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.2535 (2019).","journal-title":"JAMA Netw. Open."},{"key":"40894_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/2159-8290.CD-17-1327","volume":"8","author":"CS Grasso","year":"2018","unstructured":"Grasso, C. S. et al. Genetic mechanisms of immune evasion in colorectal cancer. Cancer Discov. 8, 730\u2013749. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1327 (2018).","journal-title":"Cancer Discov."},{"key":"40894_CR3","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1158\/1078-0432.CCR-18-2293","volume":"25","author":"JJ Harding","year":"2019","unstructured":"Harding, J. J. et al. Prospective genotyping of hepatocellular carcinoma: Clinical implications of next-generation sequencing for matching patients to targeted and immune therapies. Clin. Cancer Res. 25, 2116\u20132126. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2293 (2019).","journal-title":"Clin. Cancer Res."},{"key":"40894_CR4","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","volume":"25","author":"JJ Luke","year":"2019","unstructured":"Luke, J. J., Bao, R., Sweis, R. F., Spranger, S. & Gajewski, T. F. <article-title update=\u201cmodified\u201d original=\"WNT\/beta-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers\">WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers. Clin. Cancer Res. 25, 3074\u20133083. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1942 (2019).","journal-title":"Clin. Cancer Res."},{"key":"40894_CR5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","volume":"153","author":"D Sia","year":"2017","unstructured":"Sia, D. et al. Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features. Gastroenterology 153, 812\u2013826. https:\/\/doi.org\/10.1053\/j.gastro.2017.06.007 (2017).","journal-title":"Gastroenterology"},{"key":"40894_CR6","doi-asserted-by":"publisher","first-page":"108921","DOI":"10.1016\/j.biopha.2019.108921","volume":"115","author":"J Xue","year":"2019","unstructured":"Xue, J. et al. Intrinsic beta-catenin signaling suppresses CD8(+) T-cell infiltration in colorectal cancer. Biomed. Pharmacother. 115, 108921. https:\/\/doi.org\/10.1016\/j.biopha.2019.108921 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"40894_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.aac9935","volume":"352","author":"SC Casey","year":"2016","unstructured":"Casey, S. C. et al. MYC regulates the antitumor immune response through CD47 and PD-L1. Science 352, 227\u2013231. https:\/\/doi.org\/10.1126\/science.aac9935 (2016).","journal-title":"Science"},{"key":"40894_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger, S., Bao, R. & Gajewski, T. F. Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity. Nature 523, 231\u2013235. https:\/\/doi.org\/10.1038\/nature14404 (2015).","journal-title":"Nature"},{"key":"40894_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41416-021-01413-x","volume":"125","author":"C Pilard","year":"2021","unstructured":"Pilard, C. et al. Cancer immunotherapy: It\u2019s time to better predict patients\u2019 response. Br. J. Cancer 125, 927\u2013938. https:\/\/doi.org\/10.1038\/s41416-021-01413-x (2021).","journal-title":"Br. J. Cancer"},{"key":"40894_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.devcel.2016.08.011","volume":"38","author":"KM Loh","year":"2016","unstructured":"Loh, K. M., van Amerongen, R. & Nusse, R. Generating cellular diversity and spatial form: Wnt signaling and the evolution of multicellular animals. Dev. Cell 38, 643\u2013655. https:\/\/doi.org\/10.1016\/j.devcel.2016.08.011 (2016).","journal-title":"Dev. Cell"},{"key":"40894_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00018-022-04219-z","volume":"79","author":"R Yu","year":"2022","unstructured":"Yu, R., Zhu, B. & Chen, D. Type I interferon-mediated tumor immunity and its role in immunotherapy. Cell. Mol. Life Sci. 79, 191. https:\/\/doi.org\/10.1007\/s00018-022-04219-z (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"40894_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S2468-1253(21)00385-X","volume":"7","author":"TU Marron","year":"2022","unstructured":"Marron, T. U. et al. Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial. Lancet Gastroenterol. Hepatol. 7, 219\u2013229. https:\/\/doi.org\/10.1016\/S2468-1253(21)00385-X (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"40894_CR13","first-page":"2788","volume":"9","author":"M Bai","year":"2017","unstructured":"Bai, M. et al. The crosstalk between beta-catenin signaling and type I, type II and type III interferons in lung cancer cells. Am J Transl Res 9, 2788\u20132797 (2017).","journal-title":"Am J Transl Res"},{"key":"40894_CR14","doi-asserted-by":"publisher","first-page":"e1003416","DOI":"10.1371\/journal.ppat.1003416","volume":"9","author":"M Baril","year":"2013","unstructured":"Baril, M. et al. Genome-wide RNAi screen reveals a new role of a WNT\/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses. PLoS Pathog. 9, e1003416. https:\/\/doi.org\/10.1371\/journal.ppat.1003416 (2013).","journal-title":"PLoS Pathog."},{"key":"40894_CR15","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1038\/s41467-022-34000-6","volume":"13","author":"D Zimmerli","year":"2022","unstructured":"Zimmerli, D. et al. MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling. Nat. Commun. 13, 6579. https:\/\/doi.org\/10.1038\/s41467-022-34000-6 (2022).","journal-title":"Nat. Commun."},{"key":"40894_CR16","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1158\/0008-5472.CAN-21-1677","volume":"81","author":"B Krenz","year":"2021","unstructured":"Krenz, B. et al. MYC- and MIZ1-dependent vesicular transport of double-strand RNA controls immune evasion in pancreatic ductal adenocarcinoma. Cancer Res. 81, 4242\u20134256. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1677 (2021).","journal-title":"Cancer Res."},{"key":"40894_CR17","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1158\/2159-8290.CD-19-0620","volume":"10","author":"N Muthalagu","year":"2020","unstructured":"Muthalagu, N. et al. Repression of the type I interferon pathway underlies MYC- and KRAS-dependent evasion of NK and B cells in pancreatic ductal adenocarcinoma. Cancer Discov. 10, 872\u2013887. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0620 (2020).","journal-title":"Cancer Discov."},{"key":"40894_CR18","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1136\/gutjnl-2016-313598","volume":"67","author":"R Alberts","year":"2018","unstructured":"Alberts, R. et al. Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis. Gut 67, 1517\u20131524. https:\/\/doi.org\/10.1136\/gutjnl-2016-313598 (2018).","journal-title":"Gut"},{"key":"40894_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41420-024-01895-7","volume":"10","author":"W Huang","year":"2024","unstructured":"Huang, W. et al. Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer. Cell Death Discov. 10, 143. https:\/\/doi.org\/10.1038\/s41420-024-01895-7 (2024).","journal-title":"Cell Death Discov."},{"key":"40894_CR20","doi-asserted-by":"publisher","first-page":"e114462","DOI":"10.15252\/embj.2023114462","volume":"42","author":"SJ Kim","year":"2023","unstructured":"Kim, S. J., Kiser, P. K., Asfaha, S., DeKoter, R. P. & Dick, F. A. EZH2 inhibition stimulates repetitive element expression and viral mimicry in resting splenic B cells. EMBO J. 42, e114462. https:\/\/doi.org\/10.15252\/embj.2023114462 (2023).","journal-title":"EMBO J."},{"key":"40894_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2018.05.052","volume":"174","author":"W Sheng","year":"2018","unstructured":"Sheng, W. et al. LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade. Cell 174, 549-563 e519. https:\/\/doi.org\/10.1016\/j.cell.2018.05.052 (2018).","journal-title":"Cell"},{"key":"40894_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.devcel.2019.01.003","volume":"48","author":"S Schlesinger","year":"2019","unstructured":"Schlesinger, S. & Meshorer, E. Open chromatin, epigenetic plasticity, and nuclear organization in pluripotency. Dev. Cell 48, 135\u2013150. https:\/\/doi.org\/10.1016\/j.devcel.2019.01.003 (2019).","journal-title":"Dev. Cell"},{"key":"40894_CR23","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.83444","author":"D May","year":"2023","unstructured":"May, D. et al. Live imaging reveals chromatin compaction transitions and dynamic transcriptional bursting during stem cell differentiation in vivo. Elife https:\/\/doi.org\/10.7554\/eLife.83444 (2023).","journal-title":"Elife"},{"key":"40894_CR24","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/ni.2756","volume":"14","author":"F You","year":"2013","unstructured":"You, F. et al. ELF4 is critical for induction of type I interferon and the host antiviral response. Nat. Immunol. 14, 1237\u20131246. https:\/\/doi.org\/10.1038\/ni.2756 (2013).","journal-title":"Nat. Immunol."},{"key":"40894_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/jmcb\/mjw051","volume":"9","author":"MA Suico","year":"2017","unstructured":"Suico, M. A., Shuto, T. & Kai, H. Roles and regulations of the ETS transcription factor ELF4\/MEF. J. Mol. Cell Biol. 9, 168\u2013177. https:\/\/doi.org\/10.1093\/jmcb\/mjw051 (2017).","journal-title":"J. Mol. Cell Biol."},{"key":"40894_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fonc.2019.00220","volume":"9","author":"D Li","year":"2019","unstructured":"Li, D. et al. IRF6 is directly regulated by ZEB1 and ELF3, and predicts a favorable prognosis in gastric cancer. Front. Oncol. 9, 220. https:\/\/doi.org\/10.3389\/fonc.2019.00220 (2019).","journal-title":"Front. Oncol."},{"key":"40894_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1080\/10985549.2024.2366207","volume":"44","author":"KY Fung","year":"2024","unstructured":"Fung, K. Y. et al. Expression of interferon epsilon in mucosal epithelium is regulated by Elf3. Mol. Cell Biol. 44, 334\u2013343. https:\/\/doi.org\/10.1080\/10985549.2024.2366207 (2024).","journal-title":"Mol. Cell Biol."},{"key":"40894_CR28","doi-asserted-by":"publisher","first-page":"eadk5386","DOI":"10.1126\/sciadv.adk5386","volume":"10","author":"A Cortesi","year":"2024","unstructured":"Cortesi, A. et al. Activation of endogenous retroviruses and induction of viral mimicry by MEK1\/2 inhibition in pancreatic cancer. Sci. Adv. 10, eadk5386. https:\/\/doi.org\/10.1126\/sciadv.adk5386 (2024).","journal-title":"Sci. Adv."},{"key":"40894_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41586-024-08257-4","volume":"637","author":"A Elewaut","year":"2025","unstructured":"Elewaut, A. et al. Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. Nature 637, 716\u2013725. https:\/\/doi.org\/10.1038\/s41586-024-08257-4 (2025).","journal-title":"Nature"},{"key":"40894_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s43018-020-0048-0","volume":"1","author":"K Gong","year":"2020","unstructured":"Gong, K. et al. EGFR inhibition triggers an adaptive response by co-opting antiviral signaling pathways in lung cancer. Nat. Cancer 1, 394\u2013409. https:\/\/doi.org\/10.1038\/s43018-020-0048-0 (2020).","journal-title":"Nat. Cancer"},{"key":"40894_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41698-021-00181-4","volume":"5","author":"NJ Gurule","year":"2021","unstructured":"Gurule, N. J. et al. A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer. NPJ Precis. Oncol. 5, 41. https:\/\/doi.org\/10.1038\/s41698-021-00181-4 (2021).","journal-title":"NPJ Precis. Oncol."},{"key":"40894_CR32","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1158\/0008-5472.CAN-22-0325","volume":"82","author":"J Boumelha","year":"2022","unstructured":"Boumelha, J. et al. An immunogenic model of KRAS-mutant lung cancer enables evaluation of targeted therapy and immunotherapy combinations. Cancer Res. 82, 3435\u20133448. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-0325 (2022).","journal-title":"Cancer Res."},{"key":"40894_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41591-022-02181-8","volume":"29","author":"J Tian","year":"2023","unstructured":"Tian, J. et al. Combined PD-1, BRAF and MEK inhibition in BRAF(V600E) colorectal cancer: A phase 2 trial. Nat. Med. 29, 458\u2013466. https:\/\/doi.org\/10.1038\/s41591-022-02181-8 (2023).","journal-title":"Nat. Med."},{"key":"40894_CR34","doi-asserted-by":"publisher","first-page":"8146","DOI":"10.1038\/s41467-024-52324-3","volume":"15","author":"P Anastasiou","year":"2024","unstructured":"Anastasiou, P. et al. Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade. Nat. Commun. 15, 8146. https:\/\/doi.org\/10.1038\/s41467-024-52324-3 (2024).","journal-title":"Nat. Commun."},{"key":"40894_CR35","doi-asserted-by":"publisher","first-page":"loae002","DOI":"10.1093\/lifemeta\/loae002","volume":"3","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. IDH1 mutation inhibits differentiation of astrocytes and glioma cells with low oxoglutarate dehydrogenase expression by disturbing \u03b1-ketoglutarate-related metabolism and epigenetic modification. Life Metab. 3, loae002. https:\/\/doi.org\/10.1093\/lifemeta\/loae002 (2024).","journal-title":"Life Metab."},{"key":"40894_CR36","doi-asserted-by":"publisher","first-page":"5505","DOI":"10.1038\/s41467-021-25728-8","volume":"12","author":"J Bragelmann","year":"2021","unstructured":"Bragelmann, J. et al. MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I. Nat. Commun. 12, 5505. https:\/\/doi.org\/10.1038\/s41467-021-25728-8 (2021).","journal-title":"Nat. Commun."},{"key":"40894_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12967-021-02706-8","volume":"19","author":"SP Korpela","year":"2021","unstructured":"Korpela, S. P. et al. Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response. J. Transl. Med. 19, 43. https:\/\/doi.org\/10.1186\/s12967-021-02706-8 (2021).","journal-title":"J. Transl. Med."},{"key":"40894_CR38","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41417-023-00640-z","volume":"30","author":"V Gureghian","year":"2023","unstructured":"Gureghian, V. et al. A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma. Cancer Gene Ther. 30, 1330\u20131345. https:\/\/doi.org\/10.1038\/s41417-023-00640-z (2023).","journal-title":"Cancer Gene Ther."},{"key":"40894_CR39","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nature23465","volume":"548","author":"S Goel","year":"2017","unstructured":"Goel, S. et al. CDK4\/6 inhibition triggers anti-tumour immunity. Nature 548, 471\u2013475. https:\/\/doi.org\/10.1038\/nature23465 (2017).","journal-title":"Nature"},{"key":"40894_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/0008-5472.CAN-20-2426","volume":"82","author":"Y Adachi","year":"2022","unstructured":"Adachi, Y. et al. Inhibition of FGFR reactivates IFNgamma signaling in tumor cells to enhance the combined antitumor activity of lenvatinib with anti-PD-1 antibodies. Cancer Res. 82, 292\u2013306. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-2426 (2022).","journal-title":"Cancer Res."},{"key":"40894_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081110","author":"WJ Park","year":"2023","unstructured":"Park, W. J. & Kim, M. J. A new wave of targeting \u201cundruggable\u201d Wnt signaling for cancer therapy: Challenges and opportunities. Cells https:\/\/doi.org\/10.3390\/cells12081110 (2023).","journal-title":"Cells"},{"key":"40894_CR42","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1158\/0008-5472.CAN-11-3034","volume":"72","author":"PR Gavine","year":"2012","unstructured":"Gavine, P. R. et al. AZD4547: An orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family. Cancer Res. 72, 2045\u20132056. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3034 (2012).","journal-title":"Cancer Res."},{"key":"40894_CR43","doi-asserted-by":"publisher","first-page":"D50","DOI":"10.1093\/nar\/gkh075","volume":"32","author":"J Paces","year":"2004","unstructured":"Paces, J. et al. HERVd: The Human Endogenous RetroViruses Database: Update. Nucleic Acids Res. 32, D50. https:\/\/doi.org\/10.1093\/nar\/gkh075 (2004).","journal-title":"Nucleic Acids Res."},{"key":"40894_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/nar\/30.1.205","volume":"30","author":"J Paces","year":"2002","unstructured":"Paces, J., Pavlicek, A. & Paces, V. HERVd: Database of human endogenous retroviruses. Nucleic Acids Res. 30, 205\u2013206. https:\/\/doi.org\/10.1093\/nar\/30.1.205 (2002).","journal-title":"Nucleic Acids Res."},{"key":"40894_CR45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589. https:\/\/doi.org\/10.1016\/j.molcel.2010.05.004 (2010).","journal-title":"Mol. Cell"},{"key":"40894_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baw087","author":"S Nakagawa","year":"2016","unstructured":"Nakagawa, S. & Takahashi, M. U. gEVE: A genome-based endogenous viral element database provides comprehensive viral protein-coding sequences in mammalian genomes. Database (Oxford) https:\/\/doi.org\/10.1093\/database\/baw087 (2016).","journal-title":"Database (Oxford)"},{"key":"40894_CR47","doi-asserted-by":"publisher","first-page":"e0177119","DOI":"10.1371\/journal.pone.0177119","volume":"12","author":"P Tongyoo","year":"2017","unstructured":"Tongyoo, P. et al. EnHERV: Enrichment analysis of specific human endogenous retrovirus patterns and their neighboring genes. PLoS ONE 12, e0177119. https:\/\/doi.org\/10.1371\/journal.pone.0177119 (2017).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40894-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40894-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40894-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:02:35Z","timestamp":1776099755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40894-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40894"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40894-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12133"}}